Skip to main content
. 2016 May 9;11(5):e0152038. doi: 10.1371/journal.pone.0152038

Fig 2. Participant response rates in systemic and mucosal compartments;

Fig 2

Panel a) shows the numbers of participants with a CN54gp140 IgG antibodies in serum according to vaccination group and timepoint from randomisation. Panel b) shows the numbers of participants with CN54gp140 IgG antibodies in mucosal samples by vaccination group. Filled bars show the number of participants with detectable CN54 IgG, open bars show the number of participants with no CN54gp140 IgG antibodies.